Who's too old to screen? Prostate cancer in elderly men

Journal of the Canadian Urological Association

Volumn 3, Issue 3, 2009, Pages 205-210

  Mistry, Sandeep ^a   Mayer, Wesley ^a   Khavari, Rose ^a   Ayala, Gustavo ^a   Miles, Brian ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450208099     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.1071     Document Type: Article

References (14)

1. American Cancer Society. Cancer facts & figures 2003. Available: www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf (accessed 2009 Apr 28).
2. Lu-Yao G, Stukel TA, Yao SL Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003;95:1792-1797
3. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:185-191
4. Lin K, Lipsitz R, Miller T, et al. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:192-199
5. Noguchi M, Stamey TA, McNeal JE, et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001;166:104-109
6. Richardson TD, Oesterling JE. Age-specific reference ranges for serum prostate specific antigen. Urol Clin North Am 1997;24:339-351
7. Fowler FJ Jr, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998;104:526-532
8. Philip J, Dutta Roy S, Ballal M, et al. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? BJU Int 2005;95:969-971
9. Lu-Yao G, Stukel TA, Yao SL. Changing patterns in competing causes of death in men with prostate cancer: a population based study. J Urol 2004;171:2285-2290
10. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-248
11. Alibhai SM, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003;21:3318-3327 (Pubitemid 46606266)
12. Sweat SD, Bergstralh EJ, Slezak J, et al. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 2002;168:525-529
13. Tewari A, Johnson CC, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004;171:1513-1519
14. Stangelberger A, Waldert M, Djavan B. Prostate cancer in elderly men. Rev Urol 2008;10:111-119